The influence of platelet aggregation inhibitors on metastasis formation in mice (3LL)

  • P. Hilgard
  • H. Heller
  • C. G. Schmidt


Platelets were suggested to play a specific role in the haematogenous spread of experimental tumours. To test this hypothesis mice were treated with various inhibitors of platelet function (acetyl-salicylic acid, RA 233, ben-cyclan-, cyproheptadine). The effect of treatment on the development of lung colonies after i.v. tumour cell injection as well as on the formation of spontaneous metastases from the solid Lewis-lung carcinoma was evaluated. A significant increase of lung colonies after pretreatment with the platelet aggregation inhibitors was found. The effect of long term treatment on spontaneous metastasis formation gave equivocal results. The present investigations do not support the importance of the integrity of platelet function as a prerequisite for metastasis formation.


Specific Role Platelet Function Term Treatment Cell Injection Platelet Aggregation Inhibitor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Der Einfluß von Plättchenaggregationshemmern auf die hämatogene Metastasierung bei Mäusen (3LL)


Von verschiedenen Autoren wurde eine spezifische Rolle der Blutplättchen bei der hämatogenen Metastasierung angenommen. Zur Prüfung dieser Hypothese wurden Mäuse mit verschiedenen thrombocytenaktiven Pharmaka behandelt (Azetylsalicylsäure, RA 233, Benzyclan und Cyproheptadin), und der Effekt dieser Behandlung sowohl auf die Ausbildung von Lungenkolonien nach i.v. Tumorzellinjektion als auch auf die Spontanmetastasierung des Lewis-lung-Carcinoms wurde gemessen. Die Behandlung mit Plättchenaggregationshemmern führte zu einer signifikanten Zunahme der Lungenkolonien, während kein wesentlicher Einfluß auf die Spontanmetastasierung nachweisbar war. Die vorliegenden Ergebnisse sprechen nicht für eine pathogenetische Bedeutung der Thrombocyten bei der experimentellen Metastasierung.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Atherton, A., Busfield, D., Hellmann, K.: The effects of an antimetastatic agent, (±) — 1,2-bis (3,5-dioxopiperazin-1-yl)propane (ICRF 159), on platelet behavior. Cancer Res. 35, 953–957 (1975)Google Scholar
  2. Brecher, G., Cronkite, E.P.: Morphology and enumeration of human platelets. J. appl. Physiol. 3, 365–377 (1950)Google Scholar
  3. Gasic, G.J., Gasic, T.B., Stewart, C.C.: Antimetastatic effects associated with platelet reduction. Proc. nat. Acad. Sci. (Wash.) 61, 46–52 (1968)Google Scholar
  4. Gasic, G.J., Gasic, T.B., Galanti, N., Johnson, T., Murphy, S.: Platelet — tumor-cell interactions in mice. The role of platelets in the spread of malignant disease. Int. J. Cancer 11, 704–718 (1973)Google Scholar
  5. Gastpar, H.: Metastasierung und Blutgerinnung. Thrombos. Diathes. haemorrh. (Stuttg.) Suppl. 28, 119 (1968)Google Scholar
  6. Gastpar, H.: Stickiness of platelets and tumor cells influenced by drugs. Thrombos. Diathes. haemorrh. (Stuttg.) Suppl. 42, 291–303 (1970)Google Scholar
  7. Goldman, B., Aledort, L.M., Puszkin, E., Burrows, L.: Cyproheptadine, a new platelet deaggregating agent. Circulation 44, Suppl. 2, 68, Abstr. 233 (1971)Google Scholar
  8. Hagmar, B.: Experimental tumour metastases and blood coagulability. Acta path. microbiol. scand. 78, Suppl. 211, 5 (1970)Google Scholar
  9. Hilgard, P.: The role of blood platelets in experimental metastases. Brit. J. Cancer 28, 429–435 (1973)Google Scholar
  10. Hilgard, P., Gordon-Smith, E.C.: Microangiopathic haemolytic anaemia and experimental tumourcell emboli. Brit. J. Haemat. 26, 651–659 (1974)Google Scholar
  11. Kovács, I.B., Csalay, L., Csákváry, G.: Antithrombotic and fibrinolytic effect of bencyclane. Arzneimittel-Forsch. 21, 1553–1156 (1971)Google Scholar
  12. Lindsay,R.M., Prentice,C.R.M., Ferguson,D., Burton,J.A., McNicol,G.P.: Reduction of thrombus formation on dialyser membranes by aspirin and RA 233. Lancet 1972 II, 1287–1290Google Scholar
  13. Martin, M., Schäfer, G., Martin, U., Juraschek, H., Knüll, W.: The inhibition of thrombocyte adhesion by bencyclane. Experimental and clinical results. Thrombos. Res. 4, 741–752 (1974)Google Scholar
  14. Minsker,D.H., Jordan,P.T., MacMillan,A.: Inhibition of platelet aggregation by cyproheptadine. Proceedings of Platelet Symposium, Philadelphia, 1972. Physiological Society of Philadelphia (in press)Google Scholar
  15. Moschos, C.B., Lahiri, K., Lyons, M., Weisse, A.B., Oldewurtel, H.A., Regan, T.J.: Relation of microcirculatory thrombosis to thrombus in the proximal coronary artery: effect of aspirin, dipyridamole and thrombolysis. Amer. Heart J. 86, 61–67 (1973)Google Scholar
  16. Mustard, J.F., Packham, M.A.: Factors influencing platelet function: adhesion, release and aggregation. Pharmacol. Rev. 22, 97–187 (1970)Google Scholar
  17. Sindelar, W.F., Tralka, T.S., Ketcham, A.S.: Electron microscopic observations on formation of pulmonary metastases. J. surg. Res. 18, 137–161 (1975)Google Scholar
  18. Vane, J.R.: Inhibition of prostaglandin biosynthesis as the mechanism of action of aspirin-like drugs. Advanc. Biosci. 9, 395–411 (1973)Google Scholar
  19. Wexler, H.: Accurate identification of experimental pulmonary metastases. J. nat. Cancer Inst. 36, 641–645 (1965)Google Scholar
  20. Wood,S.,Jr.: Mechanism of establishment of tumor metastases. Pathobiology Ann. 1971, 218–308Google Scholar
  21. Wood,S.,Jr., Hilgard,P.: Aspirin and tumour metastasis. Lancet 1972, 1416–1417Google Scholar
  22. Wood, S.,Jr.: Experimental studies on the spread of cancer with special reference to fibrinolytic agents and anticoagulants. J. Med. 5, 7–22 (1974)Google Scholar
  23. Zucker, M.B., Peterson, J.: Inhibition of adenosine diphosphate-induced secondary aggregation and other platelet functions by acetylsalicylic acid ingestion. Proc. Soc. exp. Biol. (N.Y.) 127, 547–551 (1968)Google Scholar

Copyright information

© Springer-Verlag 1976

Authors and Affiliations

  • P. Hilgard
    • 1
  • H. Heller
    • 1
  • C. G. Schmidt
    • 1
  1. 1.Innere Universitätsklinik u. Poliklinik (Tumorforschung) Klinikum Essen der GHSEssenGermany

Personalised recommendations